Earnings Feed
Start Free
Home/Filings/4/0001127602-22-011678
4//SEC Filing

Finke Daniel P 4

Accession 0001127602-22-011678

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 5:02 PM ET

Size

22.1 KB

Accession

0001127602-22-011678

Insider Transaction Report

Form 4
Period: 2022-04-04
CVS HEALTH CorpCVS
Finke Daniel P
EVP/Pres, Health Care Benefits
Transactions
  • Sale

    Common Stock

    2022-04-04$100.13/sh−16,161$1,618,201→ 50,122.961 total
  • Sale

    Common Stock

    2022-04-05$100.00/sh−5,941$594,100→ 32,149.961 total
  • Exercise/Conversion

    Stock Option

    2022-04-04−27,166→ 27,166 total
    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (27,166 underlying)
  • Sale

    Common Stock

    2022-04-04$100.13/sh−12,032$1,204,764→ 38,090.961 total
  • Exercise/Conversion

    Common Stock

    2022-04-04$54.19/sh+16,161$875,765→ 66,283.961 total
  • Exercise/Conversion

    Common Stock

    2022-04-04$58.34/sh+27,166$1,584,864→ 77,288.961 total
  • Sale

    Common Stock

    2022-04-04$100.13/sh−27,166$2,720,132→ 50,122.961 total
  • Exercise/Conversion

    Stock Option

    2022-04-04−16,161→ 16,161 total
    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (16,161 underlying)
Holdings

  • Common Stock (restricted)

    15,904

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (82,066 underlying)
    82,066

  • Stock Unit (deferred)

    3,097.808

  • Common Stock (pep)

    3,097.808

  • Stock Option

    Exercise: $52.37From: 2022-05-31Exp: 2029-05-31→ Common Stock (28,640 underlying)
    28,640

  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (51,975 underlying)
    51,975
Footnotes (6)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F2]Option became exercisable in four equal annual installments, beginning on 4/1/2020.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F4]Option becomes exercisable in four equal installments, commencing 4/1/2022.
  • [F5]Option becomes exercisable in three equal installments, commencing 5/31/2022.
  • [F6]Option becomes exercisable in four equal installments, commencing 4/1/2023.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001844305

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 5:02 PM ET
Size
22.1 KB
View on SEC.gov